Sökning: WFRF:(Kaukinen A) > Outcome measures in...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06457naa a2200577 4500 | |
001 | oai:DiVA.org:oru-68770 | |
003 | SwePub | |
008 | 180907s2018 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:139012109 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-687702 URI |
024 | 7 | a https://doi.org/10.1136/gutjnl-2017-3148532 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1390121092 URI |
040 | a (SwePub)orud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Ludvigsson, Jonas F.,d 1969-u Karolinska Institutet,Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Medical epidemiology and Biostatistics, Karolinska institutet, Stockholm, Sweden; Department of Pediatrics, Örebro University Hospital, Örebro, Sweden4 aut0 (Swepub:oru)jsln |
245 | 1 0 | a Outcome measures in coeliac disease trials :b the Tampere recommendations |
264 | c 2018-02-13 | |
264 | 1 | b BMJ Publishing Group Ltd,c 2018 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies:German Research Foundation (DFG) Ministry of Research and Development (BMBF) Leibniz Foundation Biocard Simtomax Academy of Finland Competitive Research Funding of the Tampere University Hospital Sigrid Juselius Foundation Hungarian Research Fund NKFI 120392 Competitive State Research Financing of the Tampere University Hospital 9U038 | |
520 | a Objective: A gluten-free diet is the only treatment option of coeliac disease, but recently an increasing number of trials have begun to explore alternative treatment strategies. We aimed to review the literature on coeliac disease therapeutic trials and issue recommendations for outcome measures.Design: Based on a literature review of 10 062 references, we (17 researchers and 2 patient representatives from 10 countries) reviewed the use and suitability of both clinical and non-clinical outcome measures. We then made expert-based recommendations for use of these outcomes in coeliac disease trials and identified areas where research is needed. Results: We comment on the use of histology, serology, clinical outcome assessment (including patient-reported outcomes), quality of life and immunological tools including gluten immunogenic peptides for trials in coeliac disease.Conclusion: Careful evaluation and reporting of outcome measures will increase transparency and comparability of coeliac disease therapeutic trials, and will benefit patients, healthcare and the pharmaceutical industry. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng |
700 | 1 | a Ciacci, Carolinau Coeliac Center at Department of Medicine and Surgery, Scuola Medica Salernitana, University of Salerno, Salerno, Italy4 aut |
700 | 1 | a Green, Peter H. R.u Celiac Disease Center at Columbia University, New York, USA4 aut |
700 | 1 | a Kaukinen, Katriu Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; Department of Internal Medicine, Tampere University Hospital, Tampere, Finland4 aut |
700 | 1 | a Korponay-Szabo, Ilma R.u Coeliac Disease Centre, Heim Pál Children’s Hospital, Budapest, Hungary; Department of Paediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary4 aut |
700 | 1 | a Kurppa, Kalleu Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; Department of Paediatrics, Tampere University Hospital, Tampere, Finland4 aut |
700 | 1 | a Murray, Joseph A.u The Mayo Clinic, Rochester Minnesota, USA4 aut |
700 | 1 | a Lundin, Knut Erik Aslaksenu Institute of Clinical Medicine and K. G. Jebsen Coeliac Disease Research Centre, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway4 aut |
700 | 1 | a Maki, Markku J.u Science Center, Tampere University Hospital, Tampere, Finland; Tampere Centre for Child Health Research, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland4 aut |
700 | 1 | a Popp, Alinau Institute for Mother and Child Health Bucharest, University of Medicine and Pharmacy ’Carol Davila’, Bucharest, Romania; Tampere Centre for Child Health Research, University of Tampere, Tampere University Hospital, Tampere,Finland4 aut |
700 | 1 | a Reilly, Norelle R.u Division of Pediatric Gastroenterology, Columbia University Medical Center, New York, USA; Celiac Disease Center, Department of Medicine, Columbia University Medical Center, New York, USA4 aut |
700 | 1 | a Rodriguez-Herrera, Alfonsou Gupo IHP Pediatria, Sevilla, Spain4 aut |
700 | 1 | a Sanders, David S.u Academic Unit of Gastroenterology, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK4 aut |
700 | 1 | a Schuppan, Detlefu Celiac Center, University Medical Center, Johannes-Gutenberg University, Mainz, Germany; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA4 aut |
700 | 1 | a Sleet, Sarahu Coeliac UK, Buckinghamshire, UK4 aut |
700 | 1 | a Taavela, Juhau Tampere Centre for Child Health Research, University of Tampere, Tampere University Hospital, Tampere, Finland4 aut |
700 | 1 | a Voorhees, Kristinu Continuum Clinical, Northbrook, Illinois, USA4 aut |
700 | 1 | a Walker, Marjorie M.u Faculty of Health and Medicine, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia4 aut |
700 | 1 | a Leffler, Daniel A.u Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA4 aut |
710 | 2 | a Örebro universitetb Institutionen för medicinska vetenskaper4 org |
773 | 0 | t Gutd : BMJ Publishing Group Ltdg 67:8, s. 1410-1424q 67:8<1410-1424x 0017-5749x 1468-3288 |
856 | 4 | u https://doi.org/10.1136/gutjnl-2017-314853y Fulltext |
856 | 4 | u https://gut.bmj.com/content/gutjnl/67/8/1410.full.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-68770 |
856 | 4 8 | u https://doi.org/10.1136/gutjnl-2017-314853 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:139012109 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy